rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    HRMY
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Harmony Biosciences Holdings, Inc. Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinanceHRMY
      Harmony Biosciences Q3 Earnings Call Highlights
      Nov 4Yahoo FinanceHRMY
      Earnings call transcript: Harmony Biosciences misses Q3 2026 profit view
      Nov 4Investing.comHRMY
      Harmony Biosciences Hldgs Q3 2026 Earnings Call Transcript
      Nov 4BenzingaHRMY
      Harmony Biosciences Holdings earnings missed by $0.30, revenue fell short of estimates
      Nov 4Investing.comHRMY
      Harmony Biosciences reports Q3 revenue of $269M, reaffirms guidance
      Nov 4Investing.comHRMY
      Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Lag Estimates
      Nov 4Yahoo FinanceHRMY
      Harmony Biosciences earnings up next amid patent fight
      Nov 3Investing.comHRMY
      Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Q3 2026 -- GF Value Sees 45% Upside
      Nov 3Yahoo FinanceHRMY
      This Biotech's Transition Is About More Than The C-Suite

      Harmony Biosciences remains down since the company announced its CEO transition. Will an upcoming readout change that?

      Oct 28Investor's Business DailyHRMY
      Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings Growth
      Oct 28Yahoo FinanceHRMY
      Mizuho reiterates Harmony Biosciences stock rating after litigation
      Oct 23Investing.comHRMY
      Centene, Harmony Biosciences lead list of undervalued healthcare stocks (XLV:NYSEARCA)
      Oct 22Seeking AlphaHRMYCNC
      Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
      Oct 22Yahoo FinanceHRMY
      Revisiting Former Stock Picks Marriott, Logitech, Harmony Biosciences

      Technical indicators have turned bullish for the Barron’s Investor Circle stock picks.

      Oct 21Barron'sHRMYLOGIMAR
      Harmony Biosciences: A Cash Machine With A Patent Ruling Hanging Over It (NASDAQ:HRMY)
      Oct 21Seeking AlphaHRMY
      Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
      Oct 20Yahoo FinanceHRMY
      Harmony Biosciences announces CEO transition and succession

      Detailed price information for Harmony Biosciences Holdings Inc (HRMY-Q) from The Globe and Mail including charting and trades.

      Oct 14The Globe and MailHRMY
      Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Disc Medicine (IRON)

      Detailed price information for Harmony Biosciences Holdings Inc (HRMY-Q) from The Globe and Mail including charting and trades.

      Oct 14The Globe and MailHRMYIRON
      H.C. Wainwright reiterates Harmony Biosciences stock rating on leadership transition
      Oct 13Investing.comHRMY
      Why Harmony Biosciences Stock Got Mashed on Monday
      Oct 12Yahoo FinanceHRMY
      Why is Harmony Biosciences stock sliding today?
      Oct 12Investing.comHRMY
      Biotech CEO Plans His Exit; Shares Take An Unharmonious Hit

      Harmony Biosciences stock took a tumble Monday after its announced the transition of current CEO Jeffrey Dayno at the end of the year.

      Oct 12Investor's Business DailyHRMY
      Harmony Biosciences Promotes COO Peter Anastasiou to President, CEO

      Harmony Biosciences (HRMY) said Monday that Peter Anastasiou, currently chief operating officer, has

      Oct 12Yahoo FinanceHRMY
      Harmony Biosciences names Peter Anastasiou as next CEO
      Oct 12Investing.comHRMY
      Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth
      Oct 12Yahoo FinanceHRMY
      Harmony Biosciences (HRMY) Heads To European Narcolepsy Days With New Phase 3 Data
      Oct 8Yahoo FinanceHRMY
      Harmony Biosciences (HRMY) Stock Looks Below Fair Value As Shares Rose 48%

      Harmony Biosciences Holdings has delivered a 1 year share return that catches the eye, which naturally raises a question for investors who focus on earnings. Is the current US$39.34 price a fair reflection of what the business is generating today, or has sentiment moved ahead of the profit picture? The stock is up 48.1% over the past year, which puts real pressure on the question of whether recent earnings are carrying more of the load than before. The business relies heavily on monetizing a...

      Oct 8Yahoo FinanceHRMY
      Harmony BioSciences' Wakix Franchise, Pipeline Offer Multiple Value Drivers, Oppenheimer Says
      Oct 8Yahoo FinanceHRMYOPY
      Deutsche Bank Lifts Price Target on Harmony Biosciences Holdings to $42 From $39, Keeps Hold Rating
      Oct 1Yahoo FinanceHRMY
      Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days
      Oct 1Yahoo FinanceHRMY
      Oppenheimer reiterates Harmony Biosciences stock rating on patent defense
      Sep 24Investing.comHRMY
      Harmony Biosciences CMO sells $1.65m in shares
      Sep 19Investing.comHRMY
      Harmony Biosciences Holdings Insider Sold Shares Worth $1,655,416, According to a Recent SEC Filing
      Sep 18Yahoo FinanceHRMY
      Engaging In Options Activity, Kumar Budur Exercises Options Valued At $262K In Harmony Biosciences Hldgs
      Sep 10BenzingaHRMY
      Harmony Biosciences at cantor conference: growth plan widens
      Sep 10Investing.comHRMY
      Harmony Biosciences Holdings Insider Sold Shares Worth $1,453,169, According to a Recent SEC Filing
      Sep 9Yahoo FinanceHRMY
      Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?
      Sep 3Yahoo FinanceHRMY
      Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress

      PLYMOUTH MEETING, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present encore data from the company’s investigation of EPX-100 (clemizole hydrochloride) at the 16th European Epilepsy Congress being held from September 5-9, in Athens, Greece. The company is investigating EPX-100 for the treatment of Dravet syndrome and Lennox-Gastaut syndrome in the ongoing ARGUS and LIGHTHOUSE trials, respectively. These trials are current

      Sep 3Yahoo FinanceHRMY
      Harmony Biosciences stock hits 52-week high at $42.70
      Sep 2Investing.comHRMY
      Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference

      PLYMOUTH MEETING, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York, N.Y., on Thursday, September 10, 2026, at 10:20 a.m., E.T. A webcast of the fireside chat will be available on the investor page of the Harmony Biosciences website at https://ir.harmonybiosciences.com/. About Harmony BiosciencesHarmony Biosciences

      Aug 27Yahoo FinanceHRMY
      Wolfe Research initiates Harmony Biosciences stock at Outperform
      Aug 26Investing.comHRMY
      Wolfe Initiates Harmony Biosciences at Outperform With $60 Price Target

      Harmony Biosciences (HRMY) has an average rating of overweight and mean price target of $47.36, acco

      Aug 26Yahoo FinanceHRMY

      This is the newest page. Registered accounts read further back.